Global Atovaquone and Proguanil Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Atovaquone and Proguanil Market Research Report 2024
Atovaquone/Proguanil Hydrochloride is a dose combination of atovaquone and proguanil hydrochloride which acts as a blood schizonticide and also has activity against hepatic schizonts of Plasmodium falciparum.
According to Mr Accuracy reports new survey, global Atovaquone and Proguanil market is projected to reach US$ 191.2 million in 2029, increasing from US$ 129 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Atovaquone and Proguanil market research.
Key manufacturers engaged in the Atovaquone and Proguanil industry include GSK, Glenmark, Mylan Pharmaceuticals and Hetero, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Atovaquone and Proguanil were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Atovaquone and Proguanil market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Atovaquone and Proguanil market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
GSK
Glenmark
Mylan Pharmaceuticals
Hetero
Segment by Type
250 mg/100 mg
62.5mg/25mg
Adult
Paediatric
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Atovaquone and Proguanil report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Atovaquone and Proguanil market is projected to reach US$ 191.2 million in 2029, increasing from US$ 129 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Atovaquone and Proguanil market research.
Key manufacturers engaged in the Atovaquone and Proguanil industry include GSK, Glenmark, Mylan Pharmaceuticals and Hetero, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Atovaquone and Proguanil were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Atovaquone and Proguanil market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Atovaquone and Proguanil market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
GSK
Glenmark
Mylan Pharmaceuticals
Hetero
Segment by Type
250 mg/100 mg
62.5mg/25mg
Segment by Application
Adult
Paediatric
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Atovaquone and Proguanil report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source